Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 476 to 500 of 2489

TitleReference numberPublishedLast updated
Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal)TA847
Luspatercept for treating anaemia caused by beta-thalassaemia (terminated appraisal)TA843
Luspatercept for treating anaemia caused by myelodysplastic syndromes (terminated appraisal)TA844
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosisIPG746
Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and managementNG228
Fractures (complex): assessment and managementNG37
Ab interno canaloplasty for open-angle glaucomaIPG745
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal)TA842
Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA841
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodulesIPG743
Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal)TA840
Extracorporeal shockwave therapy for calcific tendinopathy in the shoulderIPG742
Advocacy services for adults with health and social care needsNG227
Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis (terminated appraisal)TA838
Digital technologies for the detection of melanomaMIB311
Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraineIPG740
YAG laser vitreolysis for symptomatic vitreous floatersIPG741
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyTA836
Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanomaTA837
Osteoarthritis in over 16s: diagnosis and managementNG226
Osteoarthritis in over 16sQS87
Pembrolizumab for adjuvant treatment of renal cell carcinomaTA830
Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroidsTA832
Zanubrutinib for treating Waldenstrom's macroglobulinaemiaTA833
Fostamatinib for treating refractory chronic immune thrombocytopeniaTA835

Results per page

  1. 10
  2. 25
  3. 50
  4. All